Skip to content

Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation

Lung Transplant Rejection

Objective: To evaluate the potential impact of molecular phenotyping of transbronchial biopsies in lung transplant recipients with allograft dysfunction, and the potential for developing a safer endobronchial mucosal biopsy format.

null

Participation Requirements

  • Sex:

    ALL

  • Eligible Ages:

    18 and up

Participation Criteria

Inclusion Criteria:

* All lung transplant recipients undergoing a biopsy as determined by their surgeon or physician.

Exclusion Criteria:

* Patients who declined participation or unable to give informed consent.

Study Location

Alberta Transplant Applied Genomics Centre, University of Alberta
Alberta Transplant Applied Genomics Centre, University of Alberta
Edmonton, Alberta
Canada

Contact Study Team

Primary Contact

Konrad S Famulski, PhD

[email protected]
1 780 492 1725
Department of Medicine, University of Alberta
Department of Medicine, University of Alberta
Edmonton, Alberta
Canada

Contact Study Team

Primary Contact

Kieran Halloran, MD

[email protected]
1 780 492 2691
University Health Network, Toronto General Hospital
University Health Network, Toronto General Hospital
Toronto, Ontario
Canada

Contact Study Team

Primary Contact

Shaf Keshavjee, MD, MSc

[email protected]
1 416-340-3863
Study Sponsored By
University of Alberta
Participants Required
More Information
Study ID: NCT02812290